These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 32976875

  • 1. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
    Intven MPW, de Mol van Otterloo SR, Mook S, Doornaert PAH, de Groot-van Breugel EN, Sikkes GG, Willemsen-Bosman ME, van Zijp HM, Tijssen RHN.
    Radiother Oncol; 2021 Jan; 154():172-178. PubMed ID: 32976875
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.
    Boekhoff MR, Bouwmans R, Doornaert PAH, Intven MPW, Lagendijk JJW, van Lier ALHMW, Rasing MJA, van de Ven S, Meijer GJ, Mook S.
    Clin Transl Radiat Oncol; 2022 May; 34():82-89. PubMed ID: 35372703
    [Abstract] [Full Text] [Related]

  • 6. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
    Mannerberg A, Persson E, Jonsson J, Gustafsson CJ, Gunnlaugsson A, Olsson LE, Ceberg S.
    Radiat Oncol; 2020 Jul 10; 15(1):168. PubMed ID: 32650811
    [Abstract] [Full Text] [Related]

  • 7. Planning target volume margin assessment for online adaptive MR-guided dose-escalation in rectal cancer on a 1.5 T MR-Linac.
    Eijkelenkamp H, Boekhoff MR, Verweij ME, Peters FP, Meijer GJ, Intven MPW.
    Radiother Oncol; 2021 Sep 10; 162():150-155. PubMed ID: 34280404
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    McDonald BA, Vedam S, Yang J, Wang J, Castillo P, Lee B, Sobremonte A, Ahmed S, Ding Y, Mohamed ASR, Balter P, Hughes N, Thorwarth D, Nachbar M, Philippens MEP, Terhaard CHJ, Zips D, Böke S, Awan MJ, Christodouleas J, Fuller CD, MR-Linac Consortium Head and Neck Tumor Site Group.
    Int J Radiat Oncol Biol Phys; 2021 Apr 01; 109(5):1606-1618. PubMed ID: 33340604
    [Abstract] [Full Text] [Related]

  • 10. Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications.
    Acharya S, Fischer-Valuck BW, Kashani R, Parikh P, Yang D, Zhao T, Green O, Wooten O, Li HH, Hu Y, Rodriguez V, Olsen L, Robinson C, Michalski J, Mutic S, Olsen J.
    Int J Radiat Oncol Biol Phys; 2016 Feb 01; 94(2):394-403. PubMed ID: 26678659
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.
    Winkel D, Bol GH, Werensteijn-Honingh AM, Intven MPW, Eppinga WSC, Hes J, Snoeren LMW, Sikkes GG, Gadellaa-van Hooijdonk CGM, Raaymakers BW, Jürgenliemk-Schulz IM, Kroon PS.
    Radiother Oncol; 2020 May 01; 146():118-125. PubMed ID: 32146257
    [Abstract] [Full Text] [Related]

  • 14. Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac.
    Gao LR, Tian Y, Wang MS, Xia WL, Qin SR, Song YW, Wang SL, Tang Y, Fang H, Tang Y, Qi SN, Yan LL, Liu YP, Jing H, Chen B, Xing NZ, Li YX, Lu NN.
    Front Oncol; 2023 May 01; 13():1039901. PubMed ID: 36741014
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S, Green O, Cai B, Yang D, Rodriguez V, Zhang H, Kim JS, Parikh PJ, Mutic S, Park JC.
    Radiat Oncol; 2018 Mar 24; 13(1):51. PubMed ID: 29573744
    [Abstract] [Full Text] [Related]

  • 17. Real-time motion-including dose estimation of simulated multi-leaf collimator-tracked magnetic resonance-guided radiotherapy.
    Persson E, Goodwin E, Eiben B, Wetscherek A, Nill S, Oelfke U.
    Med Phys; 2024 Mar 24; 51(3):2221-2229. PubMed ID: 37898109
    [Abstract] [Full Text] [Related]

  • 18. CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis.
    Boekhoff MR, Defize IL, Borggreve AS, van Hillegersberg R, Kotte ANTJ, Lagendijk JJW, van Lier ALHMW, Ruurda JP, Takahashi N, Mook S, Meijer GJ.
    Radiother Oncol; 2021 Aug 24; 161():16-22. PubMed ID: 33992628
    [Abstract] [Full Text] [Related]

  • 19. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac.
    de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, van Lier ALHMW, Hartogh MDD, van der Voort van Zyp JRN, de Groot-van Breugel EN, Raaymakers BW, Lagendijk JJW, de Boer JCJ.
    Radiother Oncol; 2020 Oct 24; 151():88-94. PubMed ID: 32622779
    [Abstract] [Full Text] [Related]

  • 20. Letter to the editor regarding the article "Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: Clinical implementation and initial experience" by Intven et al.
    Engels B, Gevaert T, De Ridder M.
    Radiother Oncol; 2021 May 24; 158():244-245. PubMed ID: 33691186
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.